Vesalio

Product brochure to be used as leave behind piece as needed. This brochure includes both NeVa and NeVa NET codes.

The document lists pVasc-compatible catheters and Cook sheaths with removable valves.

The presentation is an elevator pitch deck for initial enVast contacts.

Neva and NeVa NET cases in a simple pdf format. Note that some of these cases are available in detail on NeVa Clinical Cases Page on the website. Contact Market Development for the PowerPoint version and for help in organizing a NeVa Induction Webinar if needed.

On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot retrieval with the NeVa Drop Zone Retrieval Technique at the Vesalio Clot Interaction Workshops that took place at the Vall d’Hebron Research Institute.

NeVa VS cases in a simple pdf format. Note that some of these cases are available in detail on NeVa VS Clinical Cases Page on the website.

Doctors and stroke teams in Europe and the Middle East are training to use NeVa.

Vesalio reports NATURE trial results for the enVast assisted mechanical thrombectomy device in STEMI with large thrombus burden, presented at ESC Congress 2026.

Vesalio has received FDA 510(k) clearance for pVasc NET, a next generation peripheral thrombectomy device with an integrated dual-layer distal filter.

Vesalio announced that NATURE trial results for enVast were selected for a Late-Breaking Clinical Trials session at the ESC Congress 2026 in Munich, Germany.

Greg Cook joins Vesalio as Chief Commercial Officer to lead commercial strategy and execution across its thrombectomy platform.

Vesalio's careers page describes roles on a team working to advance standards of care in interventional neuro-radiology and cardiology.

Vesalio's clinical page presents publications and case studies on NeVa, NeVa VS, and enVast in neurothrombectomy, post-aSAH vasospasm treatment, and coronary thrombectomy.

The company’s customer service/sales support representative supports healthcare providers and sales teams through communication, order management, and inquiry resolution.

Vesalio is seeking a sales manager for direct business in Germany to grow sales and market share of its endovascular products across designated hospital accounts.

Product brochure to be used as leave behind piece as needed.

A3 Poster Format designed to hang in Neuro Cath Labs as a quick reference.

Includes design, features and benefits, clinical evidence, tips & tricks on how to maximize device impact. Contact Market Development for the PowerPoint version and for help if needed.

The article reports early multicenter experience using NeVa VS to treat cerebral vasospasm related to subarachnoid hemorrhage.

Vesalio's Board of Directors, lead by Board Chair, Mike Kujak, brings diverse skills & medical expertise, paramount to promoting the company's business success.

Vesalio's leadership team, led by CEO Steve Rybka and CTO Arthur J. Ulm, focuses on advancing stroke treatment and clot capture.

Vesalio is a medical device company advancing thrombectomy for vascular occlusion in the brain, heart, and peripheral vasculature.

Vesalio's page discusses its vision and history and describes ischemic stroke as an emergency with a high risk of death or loss of neurological function.

Vesalio is dedicated to advancing care of patients suffering from vascular occlusion by providing physicians technology designed to improve clinical outcomes.